Healthcare -
Biotechnology - NASDAQ - US
$ 3.485
1.01 %
$ 660 M
Market Cap
-8.1
P/E
ABUS - LONG-TERM INVESTMENTS
Long-term Investments ABUS - Arbutus Biopharma Corporation
6.28 M
LAST VALUE
-58.04%
2 YEAR CAGR
-22.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR